Schedule 13D ownership disclosure
DEPOMED INC
Security class unavailable · CUSIP: 249908104
Event date: 2016-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-16-004044
- Form type
- SC 13D
- Filer
- Assertio Therapeutics, Inc
- CIK
- CIK 1005201
- Filed
- Apr 07, 2016
- Reporting period
- Mar 28, 2016
- Description
- Schedule 13D beneficial ownership